Teva Reaches Tentative $4.25 Billion Settlement Over Opioids

Three open bottles of prescription medication.

Teva Pharmaceuticals, one of the country’s largest generic opioid manufacturers, announced a preliminary agreement with 2,500 local governments, states, and tribes regarding the company’s role in the deadly, ongoing opioid epidemic. The agreement, worth up to $4.25 billion, follows a year of scathing trials and previous settlements in individual cases across the country. Teva, an… Continue reading Teva Reaches Tentative $4.25 Billion Settlement Over Opioids

Teva Pharm Sees Nationwide U.S. Opioid Settlement in 2022

A large group of prescription medication bottles sit on a table as a man in the background stands with his hand on his head. The image is photographed with a very shallow depth of field with the focus being on the pill bottles in the foreground.

Teva Pharmaceutical Industries’ CEO said on Tuesday that the company remains optimistic that it will reach a nationwide settlement in lawsuits alleging that it and other drug companies fueled the U.S. opioid epidemic by the end of the year. Teva, the world’s largest generic drugmaker, increased its legal provision for opioid litigation by $1.1 billion… Continue reading Teva Pharm Sees Nationwide U.S. Opioid Settlement in 2022